GlassScriptPhysician profile
Ashlie Collins
NPI 1780275255
$5,030.84
in general payments reported to CMS, 2019-2025
16 companies · $2,523 in 2025
The $2,523 reported for 2025 was more than what 95% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $670 · 2022: $193 · 2023: $661 · 2024: $984 · 2025: $2,523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,113 · Education: $54.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,112.93 |
| Education | $54.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,432.86 | 2021-2025 | |
| Alkermes, INC. | $514.68 | 2021-2025 | Aristada, Lybalvi |
| Axsome Therapeutics, INC. | $489.52 | 2023-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $469.49 | 2023-2025 | Rexulti, Nuedexta, Abilify Asimtufii |
| Supernus Pharmaceuticals, INC. | $383.53 | 2025 | Qelbree |
| Lundbeck LLC | $316.54 | 2023-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $285.64 | 2023-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $262.63 | 2025 | Fanapt |
| Avanir Pharmaceuticals, INC. | $238.90 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $151.89 | 2024-2025 | Trintellix |
| Neurocrine Biosciences, INC. | $143.04 | 2024-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $111.29 | 2021 | |
| Janssen Pharmaceuticals, INC | $106.77 | 2021-2025 | Spravato |
| Vertical Pharmaceuticals, LLC | $66.11 | 2025 | Relexxii |
| Corium, LLC | $42.66 | 2025 | Azstarys |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $15.29 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashlie Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.